Symbol
| ATAD3A
| contributors: mct - updated : 16-11-2017
|
HGNC name
| ATPase family, AAA domain containing 3A
|
HGNC id
| 25567
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --low
|  
|
of ATAD3A/ATAD3B may be involved in the transformation pathway and the chemosensitivity of oligodendrogliomas ( | tumoral
|  
|  
| --over
|  
|
associated with poor survival in breast cancer patients | constitutional
| fusion
|  
|  
|  
|
ATAD3A-C fusion protein is uniquely associated with the severe neonatal phenotype and therefore is likely causal | constitutional
|  
| translocation
|  
|  
|
genomic rearrangements affecting the ATAD3C/ATAD3B genes on one allele and ATAD3B/ATAD3A genes on the other displays later-onset encephalopathy with cerebellar atrophy, ataxia and dystonia | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| could be an anti-apoptotic marker in lung adenocarcinoma | Therapy target
| | |
| Atad3-deficient embryos die around E7.5 due to growth retardation and a defective development of the trophoblast lineage; heterozygotes seem unaffected |